HK1040933A1 - Use of n-substituted azabicycloalkane derivates for treating diseases of the central nervous system - Google Patents
Use of n-substituted azabicycloalkane derivates for treating diseases of the central nervous systemInfo
- Publication number
- HK1040933A1 HK1040933A1 HK02102768.4A HK02102768A HK1040933A1 HK 1040933 A1 HK1040933 A1 HK 1040933A1 HK 02102768 A HK02102768 A HK 02102768A HK 1040933 A1 HK1040933 A1 HK 1040933A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- derivates
- nervous system
- central nervous
- treating diseases
- azabicycloalkane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19854147A DE19854147A1 (en) | 1998-11-24 | 1998-11-24 | Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative |
| PCT/EP1999/008734 WO2000030639A1 (en) | 1998-11-24 | 1999-11-12 | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1040933A1 true HK1040933A1 (en) | 2002-06-28 |
Family
ID=7888824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK02102768.4A HK1040933A1 (en) | 1998-11-24 | 2002-04-12 | Use of n-substituted azabicycloalkane derivates for treating diseases of the central nervous system |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1133293A1 (en) |
| JP (1) | JP2002530333A (en) |
| KR (1) | KR20010080535A (en) |
| CN (1) | CN1328455A (en) |
| AR (1) | AR021502A1 (en) |
| AU (1) | AU1775300A (en) |
| BG (1) | BG105549A (en) |
| BR (1) | BR9915589A (en) |
| CA (1) | CA2352526A1 (en) |
| CZ (1) | CZ20011796A3 (en) |
| DE (1) | DE19854147A1 (en) |
| HK (1) | HK1040933A1 (en) |
| HR (1) | HRP20010472A2 (en) |
| HU (1) | HUP0104416A3 (en) |
| IL (1) | IL143181A0 (en) |
| NO (1) | NO20012538L (en) |
| PL (1) | PL348758A1 (en) |
| SK (1) | SK7112001A3 (en) |
| TR (1) | TR200101476T2 (en) |
| WO (1) | WO2000030639A1 (en) |
| ZA (1) | ZA200103976B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2589363A1 (en) | 2004-12-13 | 2006-06-22 | Eli Lilly And Company | Spiro derivatives as lipoxygenase inhibitors |
| GB0812310D0 (en) | 2008-07-03 | 2008-08-13 | Syngenta Ltd | Novel herbicides |
| MX2015009153A (en) * | 2013-01-15 | 2016-03-04 | Novartis Ag | Use of alpha 7 nicotinic acetylcholine receptor agonists. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0348460A4 (en) * | 1987-11-12 | 1991-11-27 | American Home Products Corporation | Polycyclicamines with psychotropic activity |
| DE4427648A1 (en) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use |
| DE4341403A1 (en) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituted 3-azabicycloalkane derivatives, their preparation and use |
| DE4427647A1 (en) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-substituted azabicycloheptane derivatives, their preparation and use |
-
1998
- 1998-11-24 DE DE19854147A patent/DE19854147A1/en not_active Withdrawn
-
1999
- 1999-11-12 WO PCT/EP1999/008734 patent/WO2000030639A1/en not_active Application Discontinuation
- 1999-11-12 PL PL99348758A patent/PL348758A1/en not_active Application Discontinuation
- 1999-11-12 CZ CZ20011796A patent/CZ20011796A3/en unknown
- 1999-11-12 AU AU17753/00A patent/AU1775300A/en not_active Abandoned
- 1999-11-12 CA CA002352526A patent/CA2352526A1/en not_active Abandoned
- 1999-11-12 SK SK711-2001A patent/SK7112001A3/en unknown
- 1999-11-12 JP JP2000583522A patent/JP2002530333A/en active Pending
- 1999-11-12 KR KR1020017006445A patent/KR20010080535A/en not_active Application Discontinuation
- 1999-11-12 BR BR9915589-3A patent/BR9915589A/en not_active IP Right Cessation
- 1999-11-12 EP EP99960974A patent/EP1133293A1/en not_active Withdrawn
- 1999-11-12 TR TR2001/01476T patent/TR200101476T2/en unknown
- 1999-11-12 IL IL14318199A patent/IL143181A0/en unknown
- 1999-11-12 HU HU0104416A patent/HUP0104416A3/en unknown
- 1999-11-12 CN CN99813559A patent/CN1328455A/en active Pending
- 1999-11-24 AR ARP990105979A patent/AR021502A1/en unknown
-
2001
- 2001-05-16 ZA ZA200103976A patent/ZA200103976B/en unknown
- 2001-05-23 NO NO20012538A patent/NO20012538L/en not_active Application Discontinuation
- 2001-05-30 BG BG105549A patent/BG105549A/en unknown
- 2001-06-21 HR HR20010472A patent/HRP20010472A2/en not_active Application Discontinuation
-
2002
- 2002-04-12 HK HK02102768.4A patent/HK1040933A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20011796A3 (en) | 2002-05-15 |
| TR200101476T2 (en) | 2001-10-22 |
| WO2000030639A1 (en) | 2000-06-02 |
| BG105549A (en) | 2001-12-29 |
| CA2352526A1 (en) | 2000-06-02 |
| CN1328455A (en) | 2001-12-26 |
| HUP0104416A2 (en) | 2002-04-29 |
| HRP20010472A2 (en) | 2003-04-30 |
| BR9915589A (en) | 2001-08-07 |
| HUP0104416A3 (en) | 2002-11-28 |
| EP1133293A1 (en) | 2001-09-19 |
| NO20012538D0 (en) | 2001-05-23 |
| AU1775300A (en) | 2000-06-13 |
| SK7112001A3 (en) | 2001-12-03 |
| NO20012538L (en) | 2001-07-04 |
| JP2002530333A (en) | 2002-09-17 |
| IL143181A0 (en) | 2002-04-21 |
| DE19854147A1 (en) | 2000-05-25 |
| PL348758A1 (en) | 2002-06-03 |
| AR021502A1 (en) | 2002-07-24 |
| ZA200103976B (en) | 2002-05-16 |
| KR20010080535A (en) | 2001-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU8119001A (en) | Hybrid neuroprosthesis for the treatment of brain disorders | |
| IL133800A0 (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
| NO20005864D0 (en) | Quinasols for the treatment of brain tumor | |
| EP1063990A4 (en) | Therapy of estrogen-associated disorders | |
| HU9803018D0 (en) | Methods and compositions for the treatment and prevention of tumors, tumor-veloted disorders and cachexia | |
| PL344304A1 (en) | Combination therapy for treatment of bipolar disorders | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| IL141263A0 (en) | Methods for treatment of neurological disorders | |
| EP1207874A4 (en) | Methods of treating proliferative disorders | |
| PL345769A1 (en) | Triazolopyridines for the treatment of thrombosis disorders | |
| EE200000391A (en) | Triazine compounds for the treatment of central nervous system disorders | |
| HK1038510B (en) | Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases | |
| ATE256126T1 (en) | 5-HETEROATOM-ALKYL SUBSTITUTED 3-OXO-PYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| EP1181308A4 (en) | Methods for the treatment of neuronal atrophy-associated dementia | |
| PL347329A1 (en) | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders | |
| HUP0102886A2 (en) | Treatment of anxiety disorders | |
| HK1040933A1 (en) | Use of n-substituted azabicycloalkane derivates for treating diseases of the central nervous system | |
| CZ20011872A3 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
| IL135994A0 (en) | Combination therapy for the treatment of aids | |
| GR20010300072T1 (en) | Use of effectors of the central cholinergic nervous system | |
| PT1011678E (en) | Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders | |
| ZA985818B (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. | |
| GB0010496D0 (en) | Treatment of conditions of the central nervous system | |
| GB9821610D0 (en) | Treatment of neuropsychiatric disorders | |
| UA25221A (en) | METHOD OF TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM |